Phase
Condition
Arthritis And Arthritic Pain
Psoriasis And Psoriatic Disorders
Psoriatic Arthritis
Treatment
Telemedicine
Clinical Study ID
Ages 18-89 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Population: Patients with Psoriatic Arthritis
Age 18-89.
Active symptoms of PsA as defined by a PsA Impact of Disease (PsAID)questionnaire score >4 (range 0-10, 4 is the patient acceptable symptom state)or a patient global assessment of greater than 4 (scale 0-10).
Patients should be stable on therapy (i.e., not planning to switch therapy atthe current visit).
Meet CASPAR criteria.
Provision of signed and dated informed consent form.
Willingness to comply with all study procedures and availability for durationof the study.
Has access to a mobile phone or other mobile device.
Exclusion
Exclusion Criteria:
Inability to provide informed consent.
Plan to change systemic treatment for psoriasis or PsA in the next 4-8 weeks.
PsAID score ≤4
Study Design
Study Description
Connect with a study center
University Of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
University of Utah
Salt Lake City, Utah 84112
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.